WO2015005928A1 - Analytical method for detecting sulfated oligosaccharides - Google Patents
Analytical method for detecting sulfated oligosaccharides Download PDFInfo
- Publication number
- WO2015005928A1 WO2015005928A1 PCT/US2013/050147 US2013050147W WO2015005928A1 WO 2015005928 A1 WO2015005928 A1 WO 2015005928A1 US 2013050147 W US2013050147 W US 2013050147W WO 2015005928 A1 WO2015005928 A1 WO 2015005928A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mobile phase
- hilic
- poly
- column
- salt
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/30—Partition chromatography
- B01D15/305—Hydrophilic interaction chromatography [HILIC]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8836—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving saccharides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
Definitions
- Heparnoid Heparin and Heparan sulfate
- LMWH low-molecular weight heparin
- Fondaparinux sodium CAS 1 14870-03-0
- CAS 1 14870-03-0 is a member of
- oligosaccharides / heparins with a chemical name of 0-[2-Deoxy-6-0-sulfo-2-(su!foamino)- alpha-D-glucopyranosyl]-( 1 ⁇ 4)-0-(beta-D-glucopyranurosonyl)-( 1 -4)-0-[2-deoxy-3,6-di-0- sulfb-2-(sulfoaminc -aipha. ⁇ D-g]u ⁇
- Catalan et al. ( Anal Chem. 2009, 81, 3485) and Tatiana et al, ( Anal Chem. 2006, 78, 1774) have each described the characterization of poly-sulfated oligosaccharides by using electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser desorption and ionization mass spectrometry (MALDI-MS).
- ESI-MS electrospray ionization mass spectrometry
- MALDI-MS matrix-assisted laser desorption and ionization mass spectrometry
- oligosaccharides are due to the non-chromophore characteristics (very low UV absorption) of poly-sulfated oligosaccharides, which can restrict the use of traditional UV detectors.
- the other universal detectors such as refractive index (RI) and evaporative light scattering (ELSD) also lack enough detecting sensitivity for poly-sulfate oligosaccharides.
- RI refractive index
- ELSD evaporative light scattering
- HILIC-UPLC hydrophilic interaction ultra-performance liquid chromatography
- CAD charged aerosol detector
- MS mass spectrometer
- HILIC overcomes the challenge of retaining and separating extremely polar oligosaccharides.
- the retention mechanism for HILIC is very intricate and is a multi-modal combination of liquid-liquid partitioning, adsorption, ionic interaction and hydrophobic interaction. Therefore, HILIC, in comparison to reverse phase liquid chromatography (RPLC), provides unique selectivity and retention characteristics,
- the stationary phase used in HILIC column is, in one group of embodiments, an amide-bonded stationary phase.
- the mobile phase used in HILIC column comprises a salt, in one group of embodiments, the salt is ammonium formate.
- the concentration of the salt is higher than 50 mM. In some selected embodiments, the concentration is higher than 100 mM.
- the molar strength of the salt additive in the mobile phase composition can have a significant impact on
- the solvent of the mobile phase used in the HILIC column is acetonitriie.
- the detector used for the quantitation of poly-sulfated oligosaccharides is a charged aerosol detector (CAD).
- CAD charged aerosol detector
- aerosol particles are charged with an ionized gas (typically nitrogen). After the removal of high-mobility particles (mainly excess N 2 ions), the aerosol particles are then electrically measured. Most importantly, the method has been demonstrated to provide a uniform response for nonvolatile analytes independent of their nature.
- a separation technique utilizing HILIC, or HILIC-UPLC and (2) a detection technique such as MS or CAD allows for detection, identification and/or quantification of poly-sulfated thereby providing an effective way for analysis of synthetic poly-sulfated oligosaccharides.
- the poly-sulfated oilgosaccharide detected and/or quantitated by the methods described herein is Fondaparinux sodium.
- Figure 1(a) provides the chromatograms of HiLIC-CAD for Fondaparinux Sodium using Merck, Sequant Zic®-Hilic (3. Sum 2.1 x250mm).
- Figure 1(b) provides the chromatograms of HILIC-C AD for Fondaparinux Sodium using Merck, Sequant Zic®-pHiiic (Sum 4.6x 150mm).
- Figure 1(c) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Phenomenex, Synergi Polar-RP (4ura 4.6x250mm).
- Figure 1(d) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Phenomenex, Synergi Fusion-RP (4um 4.6x150mm).
- Figure 1(e) provide the chromatograms of HI LIC-CAD for Fondaparinux Sodium using Sepax Polar-Pyridine (1.8um 2.1 x 150mm).
- Figure 1(f) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using ES, Epic Dio! (1 Jurn 2.1 ⁇ 150mm),
- Figure 1(g) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Waters, Acquity BEH HILIC (1.7urn 2.1 x 150mm).
- Figure 1(h) provides the chromatograms of HILIC-CAD for Fondaparinux Sodium using Waters, Acquity BEH Amide (1.7um 2, l x 150mm).
- Figure 2 provides the chromatogram for Fondaparinux Sodium using Waters, BEH .Amide column (a) full scale and (b) expanded scale.
- Figure 3 provides the chromatograms in expanded scale of the drug substance analyzed using different types of salt (a) 50 niM ammonium formate (b) 100 mM ammonium formate (c) 100 mM pyridinium formate and (d) 50 mM ammonium acetate
- Figure 4 provides the chromatograms in expanded scale of the drag substance analyzed using various concentrations of ammonium formate (in expanded scale) (a) 50 mM (b) 100 mM (c) 125 mM (d) 1 50 mM (e) 175 mM and (f) 200 mM.
- Figure 5 provides the chromatograms in expanded scale of the drug substance analyzed using different organic solvents to be mobile phase (a) mobile phase A: 200 mM ammonium formate; mobile phase B: acetone and acetonitrile, 1/1 (b) mobile phase A: 200 mM ammonium formate; mobile phase B: acetonitrile.
- IPC in-process control
- H1 L1C column (a) subjecting said sample to chromatography on a hydrophilic interaction ultra-performance liquid chromatography (HILIC-UPLC) column coupled with a charged aerosol detector (CAD) or a mass spectrometer (MS), wherein the stationary phase used in H1 L1C column is an amide- bonded stationary phase; and
- HILIC-UPLC hydrophilic interaction ultra-performance liquid chromatography
- CAD charged aerosol detector
- MS mass spectrometer
- the samples used in the present methods are typically the output of synthetic production methods of poly-sulfated oligosaccharides.
- samples of the final step in the synthetic procedures can be analyzed according to the present methods by selecting aliquots of reaction mixtures. The sampling of reaction mixtures allows for detection and/or
- the sampling of reaction mixture also allows for determination of the extent of completion of a reaction.
- the final product can be subjected to the present methods to determine if further purification is needed,
- the conditions for chromatography using hydrophilic interaction ultra-performance liquid chromatography wi ll generally involve those conditions known to one of skill in the art, including, but not limited to column selection (size, length and stationary phase) as well as the mobile phase and/or pH of the mobile phase.
- the column has a stationary phase of neutral charge (e.g., diol phase or amide phase), a charged stationary phase (e.g., silica phase, aminopropyl phase), or a zwitterionic stationary phase.
- the stationary phase is an amide-bonded stationary phase. Examples 1 - 10 illustrate the results obtained from the use of various stationary phases using the methods described herein.
- the solvent used in the mob le phase is generally a polar, aprotic organic solvent or a mixture of polar, aprotic organic solvents.
- the solvent of the mobile phase used in HTL!C column is acetonitrile, acetone or a mixture of acetonitrile and acetone.
- Examples 13a- 13d illustrate the effect of various solvents and/or mixtures of solvents in the detection and/or quantitation of poly-sulfated oligosaccharides using the methods described herein.
- the mobile phase will also comprise a salt, generally a salt selected from ammonium formate, pyridimum formate and ammonium acetate, and mixtures thereof.
- the mobile phase will comprise ammonium formate.
- the mobile phase comprises a salt selected from ammonium citrate and/or ammonium oxalate. Examples 1 la-1 Id iiiustrate the effect of various salts in the mobi le phase in the detection and/or quantitation of poly-sulfated oligosaccharides using the methods described herein.
- the concentration of the salt used in the mobile phase will generally be from 25 to about 400 mM, though some optimal results are found when the salt is present in the mobile phase at concentrations of from 50 to about 200 mM. in some embodiments, the salt is present in the mobile phase at concentrations of about 50-100 mM, from about 100-200 mM, and from about 75 to 175 mM.
- Examples I2a ⁇ 12d illustrate the effect of various salt concentrations on peak resolution and peak width during the detection and/or quantitation of poly-sulfated oligosaccharides, when using the methods described herein, by employing ammonium formate as the salt,
- the methods described above are useful for detection and/or quantitation of the poly-sulfated oligosaccharide fondaparinux having the structure:
- a method for detecting and quantitating fondaparinux in a sample comprising:
- HILIC-UPLC hydrophilic interaction ultra- performance liquid chromatography
- CAD charged aerosol detector
- MS mass spectrometer
- chromatograms using the methods described herein (e.g., by use of HILIC-UPLC") and peak identification using a coupled techinque such as CAD or MS thereby confirming (detecting) the presence or absence of tbndaparinux and/or impurities in the sample.
- a coupled techinque such as CAD or MS
- the instruments involved in UPLC-MS study are Ultimate 3000 (UPLC) and micrOTOF-Q ⁇ TM (MS) which were manufactured by Thermo Fisher Dionex and Bruker Daltonics, respectively.
- the instruments involved in UPLC-CAD are ACQUITY UPLC® System and Thermo Scientific Dionex Ultra CAD which were manufactured by Waters Corporation and Thermo Fisher Dionex, respectively.
- the concentration of ammonium formate used in the mobile phase is 100 mM or higher than 100 mM.
- the volume proportion of ammonium formate : acetonitrile in the mobile phase composition is in the range of 95% - 5% ; 5% - 95%.
- the concentration of testing sample is from 15 ,ug/rnL to 30 mg/mL.
- the injection volume of testing sample is from 1 ⁇ to 5 uL.
- Examples 13a and 13b use the mixtures of acetonitrile and acetone and acetonitrile respectively as the solvent of the mobile phase for analyzing Fondaparinux Sodium according to the present invention.
- the results shown in Figure 5 indicate no obvious difference in selectivity between acetonitrile system and mixture (acetonitrile and acetone) system, a higher back pressure was observed in the system comprising the acetone/acetonitrile mixture than in the acetonitrile system.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2917460A CA2917460A1 (en) | 2013-07-11 | 2013-07-11 | Analytical method for detecting sulfated oligosaccharides |
CN201380078160.1A CN105431733B (en) | 2013-07-11 | 2013-07-11 | For detecting the analysis method of sulfated oligosaccharide |
AU2013393832A AU2013393832B2 (en) | 2013-07-11 | 2013-07-11 | Analytical method for detecting sulfated oligosaccharides |
JP2016525337A JP6208866B2 (en) | 2013-07-11 | 2013-07-11 | Analytical method for detecting sulfated oligosaccharides |
PCT/US2013/050147 WO2015005928A1 (en) | 2013-07-11 | 2013-07-11 | Analytical method for detecting sulfated oligosaccharides |
KR1020167003059A KR20160030963A (en) | 2013-07-11 | 2013-07-11 | Analytical method for detecting sulfated oligosaccharides |
EP13888999.3A EP3019861A4 (en) | 2013-07-11 | 2013-07-11 | Analytical method for detecting sulfated oligosaccharides |
IL243405A IL243405A0 (en) | 2013-07-11 | 2015-12-30 | Analytical method for detecting sulfated oligosaccharides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2013/050147 WO2015005928A1 (en) | 2013-07-11 | 2013-07-11 | Analytical method for detecting sulfated oligosaccharides |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015005928A1 true WO2015005928A1 (en) | 2015-01-15 |
Family
ID=52280428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/050147 WO2015005928A1 (en) | 2013-07-11 | 2013-07-11 | Analytical method for detecting sulfated oligosaccharides |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3019861A4 (en) |
JP (1) | JP6208866B2 (en) |
KR (1) | KR20160030963A (en) |
CN (1) | CN105431733B (en) |
AU (1) | AU2013393832B2 (en) |
CA (1) | CA2917460A1 (en) |
IL (1) | IL243405A0 (en) |
WO (1) | WO2015005928A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105628820A (en) * | 2016-01-08 | 2016-06-01 | 东营天东制药有限公司 | Fast detection method for free sulfate ion in production process of low molecular heparin |
JP2017116421A (en) * | 2015-12-24 | 2017-06-29 | 昭和電工株式会社 | Method for separating and analyzing hydrophilic compounds |
US9902971B2 (en) | 2014-06-26 | 2018-02-27 | Regeneron Pharmaceuticals, Inc. | Methods for producing a mouse XY embryonic (ES) cell line capable of producing a fertile XY female mouse in an F0 generation |
US11166915B2 (en) | 2016-09-16 | 2021-11-09 | Leukocare Ag | Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy |
US11366086B2 (en) * | 2017-09-06 | 2022-06-21 | Shanghai Green Valley Pharmaceutical Co., Ltd. | Method for determining weight-average molecular weight and content of soluble salt of acidic carbohydrates |
US11510871B2 (en) | 2016-09-16 | 2022-11-29 | Leukocare Ag | Method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110709696B (en) * | 2017-06-22 | 2022-01-04 | 昭和电工株式会社 | Method for separating and analyzing mixture of oligonucleotides |
CN109254101B (en) * | 2017-07-13 | 2021-07-09 | 中国科学院大连化学物理研究所 | Method for purifying and analyzing breast milk acid oligosaccharide |
CN112005110B (en) * | 2018-07-24 | 2022-11-29 | 深圳市海普瑞药业集团股份有限公司 | Analysis method and application of dalteparin sodium nitrite degradation product |
WO2020020145A1 (en) * | 2018-07-26 | 2020-01-30 | 深圳市海普瑞药业集团股份有限公司 | Method for analyzing sugar chain distribution of low molecular heparin and use thereof |
CN111239311A (en) * | 2018-11-28 | 2020-06-05 | 中国科学院大连化学物理研究所 | Analysis method of acid sugar and acid sugar derivative in infant excrement |
CN109633003A (en) * | 2018-12-26 | 2019-04-16 | 成都普思生物科技股份有限公司 | Radix Polygalae mouth mountain ketone III and 3,6 in a kind of measurement Radix Polygalae, the method for-two mustard acyl cane sugar contents |
CN110161147A (en) * | 2019-06-19 | 2019-08-23 | 北京三元食品股份有限公司 | The high-throughput quantification measuring method of free oligosaccharides in cream |
JP7487987B1 (en) | 2023-12-21 | 2024-05-21 | 伊那食品工業株式会社 | Analytical Method for Agro-oligosaccharides |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090090856A1 (en) * | 2007-06-01 | 2009-04-09 | Russell Philip Grant | Methods and systems for quantification of peptides and other analytes |
US20090162938A1 (en) * | 2005-11-08 | 2009-06-25 | Suomen Punainen Risti,Veripalvelu | Novel Carbohydrate Profile Compositions From Human Cells and Methods for Analysis and Modification Thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8696917B2 (en) * | 2009-02-09 | 2014-04-15 | Edwards Lifesciences Corporation | Analyte sensor and fabrication methods |
EP2306199A1 (en) * | 2009-09-29 | 2011-04-06 | Academisch Ziekenhuis Leiden Acting Under The Name Leiden University Medical Center | Reductive amination and analysis of carbohydrates using 2-picoline borane as reducing agent |
CN102101875A (en) * | 2009-12-16 | 2011-06-22 | 中国科学院大连化学物理研究所 | Method for purifying and separating oligosaccharides |
AU2010332797B2 (en) * | 2009-12-18 | 2015-05-28 | Catalent Pharma Solutions Gmbh | Pharmaceutical oral dosage form containing a synthetic oligosaccharide |
MX2012007662A (en) * | 2010-01-07 | 2012-08-23 | Polymedix Inc | Anti-heparin compounds. |
CN102759596B (en) * | 2012-07-09 | 2014-08-20 | 山东大学 | Method for detecting low-molecular-weight heparin by combining ion pair reversed phase chronmatogaphy and mass spectrum |
-
2013
- 2013-07-11 WO PCT/US2013/050147 patent/WO2015005928A1/en active Application Filing
- 2013-07-11 KR KR1020167003059A patent/KR20160030963A/en not_active Application Discontinuation
- 2013-07-11 EP EP13888999.3A patent/EP3019861A4/en not_active Withdrawn
- 2013-07-11 CA CA2917460A patent/CA2917460A1/en not_active Abandoned
- 2013-07-11 JP JP2016525337A patent/JP6208866B2/en not_active Expired - Fee Related
- 2013-07-11 CN CN201380078160.1A patent/CN105431733B/en not_active Expired - Fee Related
- 2013-07-11 AU AU2013393832A patent/AU2013393832B2/en not_active Expired - Fee Related
-
2015
- 2015-12-30 IL IL243405A patent/IL243405A0/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090162938A1 (en) * | 2005-11-08 | 2009-06-25 | Suomen Punainen Risti,Veripalvelu | Novel Carbohydrate Profile Compositions From Human Cells and Methods for Analysis and Modification Thereof |
US20090090856A1 (en) * | 2007-06-01 | 2009-04-09 | Russell Philip Grant | Methods and systems for quantification of peptides and other analytes |
Non-Patent Citations (4)
Title |
---|
DESAI, U. R. ET AL.: "Substrate specificity of the heparin lyases from flavobacterium heparinum", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, vol. 306, no. 2, 1 November 1993 (1993-11-01), pages 461 - 468, XP024753614 * |
PONNUSAMY, POOJA, REVERSE-PHASE ION-PAIRING ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY IN CHARACTERIZATION AND FINGERPRINTING OF DIVERSE SULFATED GLYCOSAMINOGLYCAN MIMETICS, May 2013 (2013-05-01), VIRGINIA COMMONWEALTH UNIVER ITY, pages 1 - 195, XP055290982 * |
See also references of EP3019861A4 * |
ZAIA, JOSEPH: "ON-LINE SEPARATIONS COMBINED WITH MS FOR ANALYSIS OF GLYCOSAMINOGLYCANS", MASS SPECTROMETRY REVIEWS, vol. 28, no. 2, 2009, pages 254 - 272, XP055165778 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9902971B2 (en) | 2014-06-26 | 2018-02-27 | Regeneron Pharmaceuticals, Inc. | Methods for producing a mouse XY embryonic (ES) cell line capable of producing a fertile XY female mouse in an F0 generation |
JP2017116421A (en) * | 2015-12-24 | 2017-06-29 | 昭和電工株式会社 | Method for separating and analyzing hydrophilic compounds |
CN105628820A (en) * | 2016-01-08 | 2016-06-01 | 东营天东制药有限公司 | Fast detection method for free sulfate ion in production process of low molecular heparin |
US11166915B2 (en) | 2016-09-16 | 2021-11-09 | Leukocare Ag | Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy |
US11510871B2 (en) | 2016-09-16 | 2022-11-29 | Leukocare Ag | Method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation |
US11366086B2 (en) * | 2017-09-06 | 2022-06-21 | Shanghai Green Valley Pharmaceutical Co., Ltd. | Method for determining weight-average molecular weight and content of soluble salt of acidic carbohydrates |
Also Published As
Publication number | Publication date |
---|---|
AU2013393832B2 (en) | 2017-11-30 |
KR20160030963A (en) | 2016-03-21 |
EP3019861A1 (en) | 2016-05-18 |
CA2917460A1 (en) | 2015-01-15 |
JP6208866B2 (en) | 2017-10-04 |
EP3019861A4 (en) | 2017-02-22 |
CN105431733A (en) | 2016-03-23 |
JP2016524166A (en) | 2016-08-12 |
CN105431733B (en) | 2019-01-22 |
AU2013393832A1 (en) | 2016-02-04 |
IL243405A0 (en) | 2016-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2013393832B2 (en) | Analytical method for detecting sulfated oligosaccharides | |
Barfi et al. | Simplified miniaturized ultrasound-assisted matrix solid phase dispersion extraction and high performance liquid chromatographic determination of seven flavonoids in citrus fruit juice and human fluid samples: hesperetin and naringenin as biomarkers | |
Campillo et al. | Dispersive liquid–liquid microextraction for the determination of macrocyclic lactones in milk by liquid chromatography with diode array detection and atmospheric pressure chemical ionization ion-trap tandem mass spectrometry | |
Sentkowska et al. | Effects of the operation parameters on HILIC separation of flavonoids on zwitterionic column | |
Bengtsson et al. | On‐line desalting and determination of morphine, morphine‐3‐glucuronide and morphine‐6‐glucuronide in microdialysis and plasma samples using column switching and liquid chromatography/tandem mass spectrometry | |
Prasanthi et al. | Development and validation of RP-HPLC method for simultaneous estimation of rifampicin, isoniazid and pyrazinamide in human plasma | |
Li et al. | Rapid determination of alkaloids in Macleaya cordata using ionic liquid extraction followed by multiple reaction monitoring UPLC–MS/MS analysis | |
US9441053B2 (en) | Analytical method for detecting sulfated oligosaccharides | |
Salas et al. | Hydrophilic interaction liquid chromatography coupled to high-resolution mass spectrometry to determine artificial sweeteners in environmental waters | |
Abdallah | HPLC and densitometric TLC methods for simultaneous determination of gemifloxacin with some co-administered drugs in human plasma | |
Ito et al. | Quantification of intact carboplatin in human plasma ultrafitrates using hydrophilic interaction liquid chromatography–tandem mass spectrometry and its application to a pharmacokinetic study | |
Yaroshenko et al. | Development and validation of a LC-MS/MS method for d-cycloserine determination in human plasma for bioequivalence study | |
Van Quekelberghe et al. | Optimization of an LC-MS method for the determination of artesunate and dihydroartemisinin plasma levels using liquid-liquid extraction | |
Luan et al. | Determination of Raddeanin A in rat plasma by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study | |
Yaroshenko et al. | Chromatographic determination of sildenafil in blood plasma using spectrophotometric and mass-spectrometric detection | |
Neu et al. | On-line solid-phase extraction high-performance liquid chromatography-tandem mass spectrometry for the quantitative analysis of tacrolimus in whole blood hemolyzate | |
Hewavitharana et al. | Separation of highly charged compounds using competing ions with hydrophilic interaction liquid chromatography–Application to assay of cellular nucleotides | |
Wang et al. | Application of solvent demulsification dispersive liquid–liquid microextraction for nicotine and cotinine measurement in human urine combined with hydrophilic interaction chromatography tandem mass spectrometry | |
Adamovics et al. | Preparative liquid chromatography of pharmaceuticals using silica gel with aqueous eluents | |
Yadeghari et al. | A microextraction liquid-chromatographic determination of aristolochic acid I in urine, flour, and aristolochiaceae fruit | |
Ahmed et al. | Quantitative determination of azithromycin in human plasma by liquid chromatography mass spectrometry and its application in Pharmackokinetic study | |
Shamsipur et al. | A manual shaking-enhanced, ultrasound-assisted dispersive liquid–liquid microextraction for the determination of betamethasone and dexamethasone: optimization using Response surface methodology | |
Wang et al. | Identification of l‐carnitine and its impurities in food supplement formulations by online column‐switching liquid chromatography coupled with linear ion trap mass spectrometry | |
Suzuki et al. | The internal standard diquat-d 4 causes errors in diquat analysis by LC–MS/MS | |
Huang et al. | Development and validation of a method for the determination of nicotinic acid in human plasma using liquid chromatography-negative electrospray ionization tandem mass spectrometry and its application to a bioequivalence study |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201380078160.1 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13888999 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 243405 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2917460 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2016525337 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20167003059 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013888999 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2013393832 Country of ref document: AU Date of ref document: 20130711 Kind code of ref document: A |